医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

UNITE HERE Cautions FDA Over Chinese Pharmaceutical Giant’s Purchase of Stake in GNC

2018年11月15日 AM12:45
このエントリーをはてなブックマークに追加


 

BOSTON

UNITE HERE has sent a letter to FDA Commissioner Dr. Scott Gottlieb, urging him to investigate the pending acquisition of a significant stake in vitamin store chain GNC by China’s Harbin Pharmaceutical Group. The letter details Harbin’s history of regulatory violations in China.

The proposed transaction between Harbin and GNC was announced in February of this year. According to GNC, Harbin will invest $300 million in GNC and create a joint venture for manufacturing, marketing, sale and distribution of GNC-branded products in China. The deal would make Harbin the largest shareholder in GNC.

“In China, Harbin has repeatedly been cited or sanctioned by government agencies for problems with its products – no fewer than 6 times since 2015, and three times in 2018 alone,” said Jeff Nelson, Deputy Director of Research at UNITE HERE. “Is it appropriate for a company like this to become the largest shareholder in GNC, which claims to set the standard in the nutritional supplement industry?”

In January, a Chinese provincial regulator sanctioned Harbin Pharmaceutical due to the presence of ammonium in certain of its drugs in excess of regulatory limits. Reportedly, this was the second time within six months that Harbin Pharmaceutical and its subsidiaries were sanctioned for this problem.

Harbin products which have been cited by Chinese regulators have included gingko pills, Siberian ginseng, and Chinese licorice. According to GNC’s website, the company sells gingko pills, Siberian root, and licorice root.

“With this track record, we do not think it is appropriate for Harbin to own a substantial portion of a significant vitamin and supplement retailer in the United States. We urge the FDA to investigate this acquisition,” said Jeff Nelson.

A major shareholder of Harbin, CITIC Capital, is part of the larger CITIC Group. CITIC owns one Marriott hotel in China. Viem Kwok, chairman of CITIC Resources Holdings, is the chairman of three companies which own three Marriott hotels in China, including two in Tibet.

About UNITE HERE

UNITE HERE represents 270,000 members working in the hotel, gaming, food service, manufacturing, textile, distribution, laundry, transportation, and airport industries in the U.S. and Canada including 17,000 employed by Marriott International. MarriottChinaObserver.org is maintained by the UNITE HERE Research Department.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181114005622/en/

CONTACT

UNITE HERE
Jeff Nelson, +1-617-480-2585
jnelson@unitehere.org

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event-Free Survival of SB3 Trastuzumab Biosimilar Candidate to Reference Trastuzumab by ADCC Activity
  • Aptorum Group Limited Announces Pricing of Initial Public Offering
  • Seattle Genetics和武田呈报 ADCETRIS® (Brentuximab Vedotin)用于表达CD30的外周T细胞淋巴瘤一线治疗3期ECHELON-2临床试验的阳性数据
  • 武田の株主がシャイアー買収案に関連した決議事項を承認
  • 武田股东批准拟收购Shire plc相关决议